There are two levels of control of the expression of the levanase operon in Bacillus subtilis: induction by fructose, which involves a positive regulator, LevR, and the fructose phosphotransferase system encoded by this operon (lev-PTS), and a global regulation, catabolite repression. The LevR activator interacts with its target, the upstream activating sequence (UAS), to stimulate the transcription of the E L complex bound at the ''؊12, ؊24'' promoter. Levanase operon expression in the presence of glucose was tested in strains carrying a ccpA gene disruption or a ptsH1 mutation in which Ser-46 of HPr is replaced by Ala. In a levR ؉ inducible genetic background, the expression of the levanase operon was partially resistant to catabolite repression in both mutants, indicating that the CcpA repressor and the HPr-SerP protein are involved in the glucose control of this operon. In addition, a cis-acting catabolite-responsive element (CRE) of the levanase operon was identified and investigated by site-directed mutagenesis. The CRE sequence TGAAAACGCTT(a)ACA is located between positions ؊50 and ؊36 from the transcriptional start site, between the UAS and the ؊12, ؊24 promoter. However, in a background constitutive for levanase, neither HPr, CcpA, nor CRE is involved in glucose repression, suggesting the existence of a different pathway of glucose regulation. Using truncated LevR proteins, we showed that this CcpA-independent pathway required the presence of the domain of LevR (amino acids 411 to 689) homologous to the BglG family of bacterial antiterminators.
Many catabolic enzymes in Bacillus subtilis are subject to carbon catabolite repression by glucose and other rapidly metabolizable carbon sources (12) . The mechanisms by which gene expression is controlled in response to nutrient availability in B. subtilis are not yet understood but are known to differ from the catabolite repression system in Escherichia coli. In E. coli, a positive regulatory protein, catabolite activator protein, in the presence of high intracellular levels of cyclic AMP (cAMP), activates transcription of a variety of catabolite-responsive operons (24) . In addition, EIIA Glc of the phosphoenolpyruvate:sugar phosphotransferase system (PTS) is involved in the glucose effect by inhibiting the activity of some sugar permeases, resulting in failure to transport the inducer (inducer exclusion). By contrast, the phosphorylated form of EIIA Glc appears to activate adenylate cyclase, the cAMP biosynthetic enzyme (35, 38) . B. subtilis does not contain detectable cAMP or adenyl cyclase (3) .
Recently, trans-active mutations that led to glucose-resistant synthesis of one or several catabolic enzymes have been isolated in B. subtilis. The corresponding genes were identified as the 43 gene rpoD (43) ; ptsH, encoding the histidine-containing phosphocarrier protein (HPr) of the PTS (11); and ccpA, encoding a putative catabolite repressor (14) .
The ptsH gene is involved in glucose regulation in B. subtilis. HPr can be phosphorylated both at a histidine residue (His-15) by enzyme I in the presence of phosphoenolpyruvate (PEP) and at a serine residue (Ser-46) by an ATP-dependent protein kinase (36) . The mutation ptsH1 changes the regulatory seryl residue to alanine (HPr-S46A), so that ATP-dependent phosphorylation is not possible. This mutant is defective for catabolite repression by glucose of gluconate kinase, glucitol dehydrogenase, mannitol-1-phosphate dehydrogenase, and the mannitol-specific PTS permease (9) . By contrast, the introduction of a negative charge on residue 46 of HPr (HPr-S46D) strongly inhibits the PEP-dependent phosphoryl transfer reaction in vitro (37) .
A transposon insertion mutation (gra26::Tn917) in the ccpA gene has been obtained and causes the loss of glucose repression of ␣-amylase synthesis. The CcpA protein exhibits similarities to the LacI/GalR repressor family (14) . A cis-active DNA sequence which overlaps the translational start site of the amyE gene has also been identified as a target of carbon catabolite repression (33) . This sequence is called the catabolite-responsive element (CRE). Both the CcpA protein and the CRE sequence are involved in glucose control of several systems, including the xylose operon, the gluconate operon, the ␤-glucanase gene, and the histidine utilization operon (17-19, 31, 46, 47) . The consensus sequence (T/A)GNAA(C/G)CGN (T/A)(T/A)NCA has been proposed for the CRE (16) . This sequence is similar to the operator sites for the LacI and GalR repressors, suggesting that CcpA represses the controlled genes by binding to the CRE DNA sequence (4) .
The levanase operon of B. subtilis (levD, levE, levF, levG, and sacC) encodes the proteins of a fructose-specific PTS and a levanase able to hydrolyze fructose polymers and sucrose (25, 27) . The expression of this operon is induced by fructose and repressed by glucose (21, 26) . The transcription of the levanase operon is controlled by (i) the RNA polymerase associated with a specific sigma factor, L , which is an equivalent of the 54 in gram-negative bacteria (7); (ii) an activator, LevR, which is a member of the NifA/NtrC family of regulators (6) ; and (iii) the LevD and LevE polypeptides, which are part of a fructosespecific PTS (27) . A current model for induction is that LevR is a positive regulator inactivated by PEP-dependent phosphorylation via the LevD and LevE polypeptides when fructose is limiting. In the presence of fructose, LevD and LevE are involved in fructose uptake and LevR is present in an active unphosphorylated form. Interestingly, the carboxy-terminal part of LevR contains a domain (domain B) with similarities to the BglG family of bacterial antiterminators, whose activity is also controlled by the PTS (1, 2, 5, 6, 22) . By testing the ability of truncated LevR activators to stimulate transcription of the levanase operon, it has recently been shown that the carboxyterminal part of this activator, including domain B, is involved in the modulation of LevR activity by the inducer, whereas the amino-terminal part of the protein plays a role in DNA binding and transcriptional activation (29) .
The mechanism by which glucose regulates the expression of the levanase operon has been partially explored (26) . In this work, we report the involvement of CcpA and HPr in the glucose-mediated repression of this operon in a wild-type genetic background. A CRE-like sequence located upstream from the ''Ϫ12, Ϫ24'' promoter was also characterized. We also supply evidence for a different pathway of glucose regulation in a genetic background allowing constitutive expression of the levanase operon.
MATERIALS AND METHODS
Bacterial strains and culture media. The B. subtilis strains used in this work are listed in Table 1 (27) , and C Glc is C medium supplemented with glucose (4 g/liter). LB, SP, and MM plates were prepared by the addition of 17 g of Bacto agar (Difco) per liter.
Transformation and phenotype characterization. Standard procedures were used to transform E. coli (39) , and transformants were selected on LB plates supplemented with ampicillin (100 g/ml). B. subtilis was transformed as previously described with plasmid or chromosomal DNA (27) , and transformants were selected on SP plates containing chloramphenicol (Cm; 5 g/ml), kanamycin (Km; 5 g/ml), erythromycin (Em; 1 g/ml) plus lincomycin (Lin; 10 g/ml), or spectinomycin (Spc; 60 g/ml).
In B. subtilis, amylase activity was detected after growth on tryptose blood agar base (TBAB; Difco) supplemented with 10 g of hydrolyzed starch per liter (Connaught). Starch degradation was detected by sublimating iodine onto the plates.
lacZ expression in liquid medium was studied as follows. Cells were grown in CSK medium supplemented with either 2 g of fructose, 10 g of glucose, 10 g of glycerol, or 10 g of glucitol per liter. Cells were harvested at an optical density at 600 nm (OD 600 ) of 0.6 to 0.8 for cultures grown in CSK and an OD 600 of 0.8 to 1 for cultures grown in CSK with sugar. ␤-Galactosidase specific activities were determined by the method of Miller (30) with cell extracts obtained by lysozyme treatment. One unit of ␤-galactosidase activity is defined as the amount of enzyme which produces 1 nmol of o-nitrophenol per min at 28ЊC. The specific activities are expressed as averages for three to five experiments.
DNA manipulations. Standard procedures were used to extract plasmids from E. coli (39) . Restriction enzymes, phage T4 DNA polymerase, phage T4 DNA ligase, and T4 polynucleotide kinase were used as recommended by the manufacturers. DNA fragments were purified from the agarose gel with a Prep-AGene kit (Bio-Rad Laboratories, Richmond, Calif.). Oligonucleotide primers were synthesized by the ␤-cyanoethylphosphoramidite method by using a Milligen/Biosearch Cyclone Plus synthesizer (Millipore Inc., Burlington, Mass.).
The PCR technique (32) with Thermus aquaticus DNA polymerase was used for amplification as previously described (28) . The oligonucleotide primers used included mismatches allowing the creation of EcoRI and BamHI restriction sites.
To perform site-directed mutagenesis, the Muta-Gene M13 in vitro mutagenesis kit (Bio-Rad) was used, and the method was based on the procedure described previously (20) . M13mp18 A5 phage DNA (28) , containing the p⌬B (Ϫ148, ϩ189) promoter region of the levanase operon, was used to introduce point mutations into the CRE-like sequence. The presence of the mutations was confirmed by DNA sequencing by the dideoxy chain termination method (40) .
Plasmid constructions. Vector pAC5 (28) , a derivative of pAF1 (13) , carries the pC194 chloramphenicol resistance gene cat and a lacZ gene between two fragments of the B. subtilis amyE gene. pAC21 (28) is a pAC5 derivative containing a p⌬B (Ϫ148, ϩ189) levDЈ-ЈlacZ translational fusion.
Plasmid pRL12 is a pBQ200 derivative containing the levR8 gene under the control of the degQ36 promoter (29) .
Plasmid pJC32 was constructed in two steps as follows. Plasmid pJC7 (27) was digested with EcoRV and ScaI. The large fragment was recircularized to give plasmid pJC31. The kanamycin resistance gene aphA3 (45) was then introduced at the single ClaI site of pJC31 to give pJC32. In this plasmid, the 3Ј end of the levR gene is disrupted by the kanamycin cassette.
Point mutations were introduced in the CRE-like sequence of the levanase operon (see above). To test the effect of these mutations on the expression of levDЈ-ЈlacZ fusions in B. subtilis, the following constructions were performed. M13 replicative forms corresponding to phage carrying each mutation were extracted and digested with EcoRI and BamHI. The corresponding EcoRIBamHI fragments were purified and cloned between the EcoRI and BamHI sites of pAC5, creating levDЈ-ЈlacZ fusions containing point mutations in the promoter region. These constructs were integrated into the B. subtilis chromosome at the amyE locus.
Random point mutations were obtained in the promoter region of the levanase operon by PCR (10), with pAC29 [p⌬F (Ϫ48, ϩ30)] as a template (28) . The PCR product was treated with BamHI and EcoRI and cloned into pAC5. About 400 colonies obtained after transformation of E. coli TGI were pooled. Plasmid DNA was extracted and used to transform B. subtilis 168 and QB169 (levR8). The resulting B. subtilis transformants were screened on MM plates containing X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) plus fructose and glucose or glucose, depending on the inducibility (strain 168) or constitutivity (QB169) of the strain. Isolates forming blue colonies on X-Gal plates in the presence of glucose were obtained. Chromosomal DNA from these isolates was purified, and the levanase promoter integrated at the amyE locus was amplified by PCR. The mutations present were then identified by direct sequencing of the PCR product.
Construction of a B. subtilis strain containing the ptsH1 mutation by transduction. PBS1 transduction was performed as previously described (44) . A PBS1 transducing lysate of strain SA003 (ptsH1) was used to transduce strain GM329 (⌬ptsGHI::erm metC3 trpC2). Met ϩ recombinants were selected on MM plates containing glucitol (20 g/liter), glutamate (2 g/liter), and tryptophan (100 g/ml). Met ϩ Em S transductants resulting from replacement of the ⌬ptsGHI::erm cassette by the ptsH1 mutation were isolated to give strain QB5223. The presence of the ptsH1 mutation was checked by DNA sequencing.
RESULTS
Expression of the levanase operon in strains without the levR gene and carrying constitutive mutations in the genes encoding the lev-PTS. Two groups of regulatory genes are involved in induction of the levanase operon: the levR gene, which encodes a positive regulator, and ptsI, levD, and levE, whose products are involved in a fructose-PTS uptake and which act as negative regulators (27) . To test the relationship between these two types of regulators, a series of strains carrying a sacCЈ-lacZ ϩ transcriptional fusion, a levR gene disruption, and various constitutive mutations in the lev-PTS were constructed ( Table 1 ). The strains were grown in CSK medium in the presence or absence of fructose as the inducer, and the ␤-galactosidase activities were measured ( Table 2 ). The levD6, levE7, ptsI6, and ptsH::cat mutations allowed constitutive expression of the levanase operon, but constitutive expression was abolished in the strain with a levR gene disruption, indicating that the levR gene is epistatic over the genes levD, levE, ptsH, and ptsI.
Carbon catabolite repression of expression of the levanase operon by various sugars. The repression exerted by carbon sources (glucose, glycerol, fructose, or glucitol) on the expression of a p⌬B (Ϫ148, ϩ189) levDЈ-ЈlacZ translational fusion was determined in an inducible (QB5081) and in a levR8 constitutive (QB5091) strain. The mutation levR8 leads to the synthesis of a truncated LevR polypeptide (LevR798) (6) . ␤-Galactosidase activities were measured after growth of strains QB5081 and QB5091 in CSK medium supplemented with sugars at a final concentration of 1% (Table 3 ). The expression of the levanase operon in strain QB5081 is inducible by fructose, so 0.2% fructose was also added to the culture medium as indicated in Table 3 . The addition of glucose resulted in the strongest repression, with 5% residual activity in a wild-type inducible background and 0.8% residual activity in the levR8 constitutive mutant. Similarly, the repression by glucitol was 3-fold in the wild-type and 30-fold in the levR8 background. Two other constitutive mutants, levD6 (QB5185) and levE7 (QB5186), were also sensitive to catabolite repression, with 18 and 4% residual activity, respectively (Table 4) . Glycerol affected the constitutive expression of the levanase operon (sixfold decrease) ( Table 3) but not expression of the operon in (26), fructose seems to play a dual role in the expression of the levanase operon, as an inducer at low concentrations in the wild-type background and as a corepressor at high concentrations in the wild-type context or in constitutive mutants. Inducible expression of the levanase operon in ccpA and ptsH1 mutants. A transposon insertion in the ccpA gene, which codes for a protein with similarities to the LacI/GalR repressor family, and the ptsH1 mutation, which changes the seryl 46 residue of HPr to alanine, preventing phosphorylation of the protein by an ATP-dependent protein kinase, cause the loss of glucose repression of several catabolic genes (9, 14) . To investigate the role of CcpA and HPr(Ser-P) in catabolite repression of the levanase operon, a ptsH1 mutation and a ccpA gene disruption (ccpA::Tn917) were introduced into strains carrying a translational levDЈ-ЈlacZ fusion in a wild-type inducible levR ϩ background. A double ccpA ptsH1 mutant was also obtained ( Table 1) . The ␤-galactosidase activity was measured after growth of the strains in CSK, CSK-fructose, and CSK-fructoseglucose (Table 4) .
While the ptsH::cat gene disruption led to constitutive expression of the levanase operon (Table 2) , the levDЈ-ЈlacZ fusion remains inducible in strain QB5224 (levR ϩ ptsH1), suggesting that ATP-dependent phosphorylation of HPr is not involved in the specific regulation by fructose of the LevR activator mediated by the lev-PTS. This is in agreement with the active fructose uptake via the lev-PTS observed in the ptsH1 mutant (data not shown).
The effect of glucose on the inducible expression of the levDЈ-ЈlacZ fusion was also tested in strains QB5081 (ccpA
, and QB5234 (ccpA::Tn917 ptsH ϩ ). The ␤-galactosidase activity was decreased about three-and twofold by the addition of glucose in the ptsH1 and ccpA::Tn917 mutants, respectively. The corresponding decrease was 17-fold in the ptsH ϩ ccpA ϩ isogenic wild-type strain and 1.4-fold in the ptsH1 ccpA double mutant QB5233 (Table  4 ). The ptsH1 mutant encoding the modified HPr-S46A and the ccpA mutant are partially resistant to glucose repression of the levanase operon. Therefore, HPr(Ser-P) and the CcpA repressor play a major role in carbon catabolite repression of the levanase system in the wild-type inducible background.
Glucose repression independent of CcpA and HPr(Ser-P) in constitutive mutants of the levanase operon. The role of CcpA and HPr(Ser-P) in glucose control was investigated more precisely by testing the effect of ptsH1 and ccpA mutations on the regulation of the levanase operon in levD6, levE7, and levR8 constitutive mutants. Strains containing the ptsH1 or ccpA mutation, a levDЈ-ЈlacZ translational fusion, and levD6, levE7, or levR8 mutations were constructed as indicated in Table 1 . The doubling time in C medium in the presence of glucose was 110 min for the ptsH1 mutants, compared with 65 min for the wild-type ptsH ϩ strain. As a control, we also measured fructose uptake by the lev-PTS in the levR8 ptsH ϩ and levR8 ptsH1 strains. The levR8 constitutive mutant was used to avoid uptake by the other fructose-PTS of B. subtilis, whose expression is inducible by fructose (27) . In strain QB5229 (levR8 ptsH1), the uptake rate was increased twofold compared with that of QB5091 (levR8) (data not shown). The ptsH1 mutant has a slightly increased uptake rate for other carbohydrates also (9, 37) , and the reason for this phenomenon remains to be determined.
The effect of glucose and fructose on the constitutive expression of the levanase operon in the ptsH1 and ccpA mutants was tested by comparing the ␤-galactosidase activity measured after growth on CSK and CSK-glucose or CSK-fructose ( Table  4 ). The ptsH1 mutation corresponding to the modified HPr-S46A had no effect on glucose repression of a levDЈ-ЈlacZ fusion in the constitutive levR8 (QB5229), levE7 (QB5230), and levD6 (QB5226) backgrounds compared with that in their isogenic wild-type strains (QB5091, QB5186, and QB5185, respectively). Furthermore, the ccpA gene disruption did not affect glucose or fructose control of the levanase operon in the levR8 constitutive background (QB5236). In a levE7 mutant (QB5267), glucose repression was only partially relieved by the ccpA gene disruption (8-fold instead of 27-fold repression in the ccpA ϩ strain) ( Table 4 ). These results indicate that repression by glucose and fructose of the levanase operon in the levD6, levE7, and levR8 constitutive mutants is not or is only weakly affected by the CcpA repressor and HPr(Ser-P). The existence of other pathways of regulation will be considered in the Discussion.
Characterization of the CRE sequence involved in glucose repression of expression of the levanase operon. A DNA sequence, TGAAAACGCTT(a)ACA, located between positions Ϫ50 and Ϫ36 from the transcriptional start site of the levanase operon, has similarities to the CRE involved in glucose repression of several genes in B. subtilis (4, 16 ). An additional A at position Ϫ39 is present in the levanase promoter region compared with the CRE consensus sequence (Fig. 1) .
Specific deletion of the CRE-like sequence is difficult because the spacing between the Ϫ12, Ϫ24 promoter and the a Cultures were grown at 37ЊC in CSK medium in the presence of 0.2% fructose and either glucose, glycerol, or glucitol (1%). ␤-Galactosidase specific activities were determined as indicated in Table 2 , footnote a.
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upstream activating sequence (UAS) is crucial for the activation of transcription by LevR. To test the involvement of the CRE-like sequence in catabolite repression, point mutations were therefore introduced by site-directed mutagenesis: the conserved C residues at positions Ϫ37 and Ϫ44 were substituted (Fig. 1) . A CRE-like sequence lacking the additional base at position Ϫ39 was also constructed. To avoid the modification of the spacing between the promoter and the UAS, a base was added at position Ϫ36 in pAC76 (Fig. 1) . The phenotypes of the corresponding mutants were analyzed after integration of the mutated p⌬B (Ϫ148, ϩ189) levDЈ-ЈlacZ fusion at the amyE locus of the wild-type and of the constitutive levR8 strains. The ␤-galactosidase activities of the different CRE mutants were assayed after growth in CSK medium in the presence or absence of 0.2% fructose and 1% glucose ( Table  5) .
As observed for the ccpA gene disruption and the ptsH1 mutation, the introduction of point mutations in the CRE-like sequence in a levR8 mutant has no significant effect on glucose repression (Table 5 ). In a levR ϩ background, the C 3 A modifications at positions Ϫ44 and Ϫ37 and a C 3 T change at position Ϫ37 decreased glucose regulation (3-, 6-, and 4-fold repression, respectively) compared with the wild-type CRE (16-fold). Thus, the CRE-like sequence is a cis-acting element in catabolite repression of the levanase operon. In addition, the induced level of ␤-galactosidase synthesis was increased twofold for the C 3 A (Ϫ44) and C 3 T (Ϫ37) modifications. As proposed previously (26) , fructose is probably involved in two independent phenomena, induction and repression. Mutations in the CRE-like sequence may partially derepress the fructose-induced expression of the levanase operon. This dual effect of the inducer is also a possible explanation for the absence of induction when an improved CRE-like sequence lacking the additional A at position Ϫ39 is present.
Mutants were also obtained by random mutagenesis by PCR amplification of the p⌬F (Ϫ148, ϩ30) promoter region. The transformants obtained after reintroduction of the p⌬F levDЈ-ЈlacZ fusions into B. subtilis were screened for increased ␤-galactosidase activity in the presence of glucose and X-Gal in both wild-type and constitutive levR8 strains. Mutations at positions Ϫ48, Ϫ46, Ϫ40, and Ϫ38 were isolated (Table 5 ). All mutations mapped in the CRE-like sequence, confirming the involvement of CRE in the glucose repression of the levanase operon. Interestingly, A 3 G modifications at positions Ϫ48 and Ϫ38 were isolated in a levR8 background, leading to increased ␤-galactosidase activity in both CSK and CSK-glucose. However, the glucose repression factor remained high: 90 for the A 3 G mutation at Ϫ48 and 77 for the A 3 G substitution at position Ϫ38. In the levR ϩ background, all the mutations isolated led to partial derepression of the glucose effect ( Table  5) .
The CRE sequence between positions Ϫ50 and Ϫ36 is there- a Cultures were grown at 37ЊC in CSK medium in the presence and absence of 0.2% fructose (CSK-Fru) and 1% glucose (CSK-Glc). ␤-Galactosidase specific activities were determined in extracts prepared from exponentially growing cells (OD 600 , 0.6 to 0.8 for CSK and 0.8 to 1 for CSK with sugars).
b ND, not determined.
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on January 7, 2018 by guest http://jb.asm.org/ fore a cis-acting element involved in glucose repression of the levanase operon. All the mutations isolated after random mutagenesis mapped in this CRE sequence even when screened in a levR8 mutant. It is thus unlikely that another cis-acting sequence is present in the p⌬F (Ϫ148, ϩ30) fragment of the levanase promoter.
CcpA requirement for catabolite repression in strains containing truncated LevR polypeptides. Regulation by glucose of the levanase operon was affected by a ccpA gene disruption in the presence of a wild-type LevR but not in the presence of the truncated LevR798 polypeptide (levR8). Truncated LevR proteins which are active when present in monocopy, leading to constitutive expression of the levanase operon, have been identified (29) . A ccpA gene disruption by a cassette conferring resistance to spectinomycin was introduced into strains containing a sacCЈ-lacZ ϩ transcriptional fusion and various singlecopy levR alleles at the amyE locus. ␤-Galactosidase activities were measured in CSK medium in the presence and absence of 1% glucose (Table 6 ). In a ccpA ϩ background, the expression of the levanase operon in the presence of LevR824, LevR798, LevR723, and LevR407 (Fig. 2) was repressed by glucose about 50-, 160-, 100-, and 35-fold, respectively. The ccpA gene disruption had no effect on glucose repression in strains containing LevR824, LevR798, or LevR723 (Table 6 ). The expression of the levanase operon in the presence of LevR407 was repressed only 2-fold in a strain carrying the ccpA gene disruption but 35-fold in a ccpA ϩ isogenic strain. Both the constitutive LevR407 polypeptide containing only domain A and the wild-type LevR ϩ polypeptide were sensitive to the ccpA pathway for catabolite repression. Thus, the carboxy-terminal part of LevR, including domain B, is necessary for catabolite repression independent of CcpA.
We tested the effect of overproduction of the LevR798 polypeptide on glucose repression. The levR8 gene was expressed under the control of the strong promoter degQ36 on a multicopy plasmid (pRL12) in strain QB5176 containing a levR gene disruption and a levDЈ-ЈlacZ translational fusion. The ␤-galactosidase activity measured after growth in CSK was 1,200 U/mg of protein in the absence of glucose and 250 U/mg of protein in the presence of glucose. The repression by glucose was therefore lower when LevR798 was overproduced (5-fold reduction) than when it was produced from a single copy (160-fold) ( Table 6 ). This phenomenon was also observed for LevR ϩ (data not shown).
DISCUSSION
In gram-positive bacteria, the HPr protein is phosphorylated twice, at a histidine residue (His-15) by EI in the presence of PEP, and at a serine residue (Ser-46) by an ATP-dependent kinase. Induction of the levanase operon in the presence of fructose may involve PEP-dependent phosphorylation via the lev-PTS (27, 42) . EI, HPr, LevD, and LevE may contribute a The mutated p⌬B levDЈ-ЈlacZ and p⌬F levDЈ-ЈlacZ translational fusions were introduced at the amyE locus of the wild-type and the constitutive levR8 strains. The mutants obtained are listed in Table 1 . ␤-Galactosidase activities were determined as described in Table 4 , footnote a.
b ND, not determined. either to uptake and phosphorylation of fructose or to the phosphorylation and thus inactivation of the transcriptional regulator LevR when fructose is present in limiting amounts. As shown in Table 2 , there is an absolute requirement for the levR gene even in the presence of constitutive mutations in the lev-PTS. ATP-dependent phosphorylation of HPr is not involved in specific regulation of the LevR activator by fructose. Indeed, in the ptsH1 (HPr-S46A) mutant, fructose is transported via the lev-PTS, with a twofold increase in the uptake rate (data not shown), and the levanase operon is inducible (Table 4 ). In the ptsH1 mutant, serine 46 of HPr is replaced by a nonphosphorylatable alanyl residue, and synthesis of gluconate kinase, glucitol dehydrogenase, mannitol-1-phosphate dehydrogenase, the ␤-glucanase enzyme, and the mannitolspecific PTS permease were all released from repression by glucose, whereas synthesis of inositol dehydrogenase was only partially resistant to glucose repression (9, 19) . The expression of the levanase operon was also partially insensitive (with a residual threefold repression factor) to the glucose effect in a ptsH1 mutant (Table 4 ). This indicates that ATP-dependent phosphorylation at Ser-46 is directly or indirectly involved in catabolite repression of the levanase operon. Glycolytic intermediates, including fructose 1,6-bisphosphate, seem to control both the ATP-dependent phosphorylation of HPr by the serine kinase (36) and catabolite repression of gluconate and inositol operons in B. subtilis (23, 34) . Most of the enzymes whose synthesis is insensitive to catabolite repression in the ptsH1 mutant are also controlled by the CcpA repressor (9, 19, 31) . We confirmed the role of the CcpA regulator in glucose repression of the levanase operon in a wild-type inducible context (Table 4) . HPr(Ser-P) and CcpA participate in a common pathway controlling the synthesis of several carbohydrate catabolic enzymes in the presence of glucose, including those encoded by the levanase operon. CcpA specifically interacts with HPr(Ser-P), and this interaction required the presence of fructose 1,6-bisphosphate, providing a link between glycolytic activity and carbon catabolite repression (8) . The formation of the CcpA-HPr(Ser-P) complex might allow the repressor to bind to the CRE DNA sequence associated with most of the regulated genes (4, 15, 16) . In the case of the levanase operon, we cannot assume that the regulation takes place at the transcriptional level, since we used a levDЈ-ЈlacZ translational fusion. However, it seems likely that the ccpA pathway modulates the expression of the levanase operon at the transcriptional level, as proposed for the other systems controlled by CcpA (17, 31, 33, 47) .
The cis-active CRE of the levanase operon, which is located in the p⌬B (Ϫ148, ϩ189) fragment of the promoter, conferred catabolite repression on the levDЈ-ЈlacZ translational fusion (Table 3) . A unique DNA sequence, TGAAAACGCTT(a) ACA (Fig. 1) , located between positions Ϫ50 and Ϫ36, has similarities to the CRE consensus sequence but has an additional A residue. Carbon catabolite repression was decreased by point mutations in the CRE-like sequence, with 3-to 5-fold repression instead of 16-fold in the presence of the wild-type sequence. Thus, the DNA sequence TGAAAACGCTT(a)ACA is involved in carbon catabolite repression of the levanase operon, probably as the target for the CcpA-HPr(Ser-P) complex (Fig. 3) . Most of the CRE sequences characterized to date are located in the coding sequence of the corresponding gene or close to the transcriptional start site (16) . In the case of the levanase operon, the cis-acting CRE sequence is upstream from the Ϫ12, Ϫ24 promoter. The molecular mechanism mediating repression in the presence of the CRE sequence and the CcpA protein remains unknown. However, a mechanism involving direct competition for binding of the RNA polymerase-54 complex seems unlikely because mutations in the CRE-like sequence are not active in the presence of a truncated LevR798 activator ( Table 5 ). The binding of CcpA in the promoter region between the LevR target (UAS) and the Ϫ12, Ϫ24 promoter may modify the conditions of protein-protein contact between LevR and the RNA polymerase associated with 54 that is necessary for the melting of DNA and the activation of transcription (Fig. 3) .
Several lines of evidence suggest that the catabolite repression of the levanase operon is complex, with various different pathways: (i) in ptsH1 and ccpA::Tn917 mutants, there was residual repression by glucose; (ii) the repression by various sugars differed in wild-type and levR8 strains; (iii) fructose acts as either an inducer or a corepressor, depending on the concentration and on the inducibility or constitutivity of the lev system; and (iv) neither HPr(Ser-P), CcpA, nor the CRE sequence is involved in glucose repression in a background constitutive for the levanase operon. In particular, in a levR8 strain encoding a truncated LevR798 polypeptide, repression by glucose is extremely strong compared with that observed in the wild-type or the levD6 and levE7 constitutive mutants and is independent of the CcpA pathway (Table 4 ). These results suggest that the phosphorylation state and the structure of the LevR regulator are important to the response to catabolite repression. We therefore tested the dependence of LevR on the CcpA catabolite repression pathway by using several truncated LevR polypeptides (29) (Table 6, Fig. 2 ). The LevR407 regulator containing domain A, homologous to that found in the NifA/NtrC family of regulators, was dependent on the CcpA pathway. All the truncated LevR proteins containing the region between amino acids 407 and 723 were CcpA independent. Domain B of LevR (411 to 689) is homologous to the BglG/SacY/SacT family of bacterial antiterminators and may play a role in catabolite repression. The possibility of an involvement of LevR in catabolite repression is supported by the partial insensitivity to glucose when the LevR798 polypeptide was overproduced. The involvement of a specific regulator in glucose control has been proposed for the xylose operon of Bacillus licheniformis (41) . Glucose regulation of this operon is mediated via an anti-inducer effect of glucose on the XylR (41) . xylR-dependent repression by glucose has also been shown for the xylose operon of B. subtilis (18) . The LevR activator could be the target of other regulators important for glucose control. The isolation of mutations affecting genes other than those of the CcpA pathway could help in the identification of such regulators. However, one possibility is the direct involvement of HPr. Indeed, in addition to the negative regulation exerted by the lev-PTS, the LevR activator requires the presence of HPr to be fully active. This requirement is particularly strong in the presence of LevR798 (42) . In vitro phosphorylation of LevR by EI and HPr has been obtained (42) , suggesting the existence of a second PEP-dependent phosphorylation site, as already proposed for the SacT regulator (2) . Interestingly, the part of LevR necessary for HPr and CcpA dependence is the same, domain B (Table 6 ) (42). This second PEP-dependent phosphorylation of LevR by EI and HPr could be involved in the transduction of information to this activator about the availability of metabolizable sugars in the cell. The complex role of fructose, which could modify the phosphorylation state of LevR at both sites, is discussed in the accompanying paper (42) . The demonstration of a link between the phosphorylation of LevR by HPr and the glucose regulation of the levanase operon deserves further investigation.
